Results 291 to 300 of about 2,184,778 (369)
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri +12 more
wiley +1 more source
Blueprint of the distinct metabolite profiles of healthy pig heart chambers. [PDF]
Haikonen R +9 more
europepmc +1 more source
Abstract Aims Myocardial inflammation and impaired mitochondrial oxidative capacity are hallmarks of heart failure (HF) pathophysiology. The extent of myocardial inflammation in patients suffering from ischaemic cardiomyopathy (ICM) or dilated cardiomyopathy (DCM) and its association with mitochondrial energy metabolism are unknown.
Julius Borger +15 more
wiley +1 more source
Novel FLNC and TGFB3 Mutations in Early Onset Familial Atrial Fibrillation With Diastolic Dysfunction. [PDF]
Xu H, Li Y, Niu X, Chen K, Liu T, Fu H.
europepmc +1 more source
Biphasic effects on human atrial arrhythmogenicity of L-type calcium channel mutations associated with a Brugada/Short QT overlap syndrome - insights from a multiscale simulation study. [PDF]
Xiang Y, Hancox JC, Zhang H.
europepmc +1 more source
Autonomic dysregulation and atrial arrhythmias. [PDF]
Mikhailov A, Arora R, Pfenniger A.
europepmc +1 more source
Focal Constrictive Pericarditis, an Unusual Cause for Biventricular Failure. [PDF]
Parachikkottil F +5 more
europepmc +1 more source
Reframing the role of glucagon‐like peptide 1 receptor agonists in cardiovascular medicine
ESC Heart Failure, Volume 12, Issue 2, Page 923-926, April 2025.
Riccardo M. Inciardi +3 more
wiley +1 more source
Unravelling Sex Disparities in the Pathophysiology of Atrial Fibrillation: Review of the Current Evidence. [PDF]
Antoun I +11 more
europepmc +1 more source

